AU1897199A - Use of formoterol in medicament for inflammation/allergy in upper airways - Google Patents
Use of formoterol in medicament for inflammation/allergy in upper airwaysInfo
- Publication number
- AU1897199A AU1897199A AU18971/99A AU1897199A AU1897199A AU 1897199 A AU1897199 A AU 1897199A AU 18971/99 A AU18971/99 A AU 18971/99A AU 1897199 A AU1897199 A AU 1897199A AU 1897199 A AU1897199 A AU 1897199A
- Authority
- AU
- Australia
- Prior art keywords
- formoterol
- allergy
- inflammation
- medicament
- upper airways
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 206010020751 Hypersensitivity Diseases 0.000 title 1
- 206010061218 Inflammation Diseases 0.000 title 1
- 208000026935 allergic disease Diseases 0.000 title 1
- 230000007815 allergy Effects 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 title 1
- 229960002848 formoterol Drugs 0.000 title 1
- 230000004054 inflammatory process Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9704644 | 1997-12-12 | ||
| SE9704644A SE9704644D0 (en) | 1997-12-12 | 1997-12-12 | New use |
| PCT/SE1998/002278 WO1999030703A1 (en) | 1997-12-12 | 1998-12-10 | Use of formoterol in medicament for inflammation/allergy in upper airways |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1897199A true AU1897199A (en) | 1999-07-05 |
Family
ID=20409370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU18971/99A Abandoned AU1897199A (en) | 1997-12-12 | 1998-12-10 | Use of formoterol in medicament for inflammation/allergy in upper airways |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1037620A1 (en) |
| JP (1) | JP2002508319A (en) |
| AU (1) | AU1897199A (en) |
| SE (1) | SE9704644D0 (en) |
| WO (1) | WO1999030703A1 (en) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9903995D0 (en) * | 1999-11-03 | 1999-11-03 | Astra Ab | New combination |
| US6667344B2 (en) | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
| US20030055026A1 (en) | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
| EP1474118A1 (en) * | 2002-02-01 | 2004-11-10 | AstraZeneca AB | Composition for inhalation |
| TW200510277A (en) | 2003-05-27 | 2005-03-16 | Theravance Inc | Crystalline form of β2-adrenergic receptor agonist |
| TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
| ES2265276B1 (en) | 2005-05-20 | 2008-02-01 | Laboratorios Almirall S.A. | DERIVATIVES OF 4- (2-AMINO-1-HYDROXYETHYL) Phenol as agonists of the BETA2 ADRENERGIC RECEIVER. |
| ES2306595B1 (en) | 2007-02-09 | 2009-09-11 | Laboratorios Almirall S.A. | NAPADISYLATE SALT OF 5- (2 - ((6- (2,2-DIFLUORO-2-PHENYLETOXI) HEXIL) AMINO) -1-HYDROXYETHYL) -8-HYDROXYCHINOLIN-2 (1H) -ONE AS ADRENERGIC RECEIVER AGONIST BETA2 . |
| ES2320961B1 (en) | 2007-11-28 | 2010-03-17 | Laboratorios Almirall, S.A. | DERIVATIVES OF 4- (2-AMINO-1-HYDROXYETHYL) PHENOL AS BETA2 ADRENERGIC RECEIVER AGONISTS. |
| EP2096105A1 (en) | 2008-02-28 | 2009-09-02 | Laboratorios Almirall, S.A. | Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the b2 adrenergic receptor |
| EP2228368A1 (en) | 2009-03-12 | 2010-09-15 | Almirall, S.A. | Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one |
| EP2386555A1 (en) | 2010-05-13 | 2011-11-16 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities |
| ITRM20110083U1 (en) | 2010-05-13 | 2011-11-14 | De La Cruz Jose Antonio Freire | PLATE FOR THE CONSTRUCTION OF TRUCKS FOR AIRPLANES |
| EP2578570A1 (en) | 2011-10-07 | 2013-04-10 | Almirall, S.A. | Novel process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one via novel intermediates of synthesis. |
| EP2592078A1 (en) | 2011-11-11 | 2013-05-15 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities |
| EP2592077A1 (en) | 2011-11-11 | 2013-05-15 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities |
| EP2641900A1 (en) | 2012-03-20 | 2013-09-25 | Almirall, S.A. | Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor. |
| EP2934594B1 (en) | 2012-12-18 | 2019-09-04 | Almirall, S.A. | Cyclohexyl and quinuclidinyl carbamate derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities . |
| TWI643853B (en) | 2013-02-27 | 2018-12-11 | 阿爾米雷爾有限公司 | a salt of 2-amino-1-hydroxyethyl-8-hydroxyquinoline-2(1H)-one derivative having both β2 adrenergic receptor agonist and M3 muscarinic receptor antagonist activity |
| TW201517906A (en) | 2013-07-25 | 2015-05-16 | Almirall Sa | Combinations comprising MABA compounds and corticosteroids |
| TWI641373B (en) | 2013-07-25 | 2018-11-21 | 阿爾米雷爾有限公司 | Salt of 2-amino-1-hydroxyethyl-8-hydroxyquinoline-2(1H)-one derivative having activity of both a muscarinic receptor antagonist and a β2 adrenergic receptor agonist |
| TW201617343A (en) | 2014-09-26 | 2016-05-16 | 阿爾米雷爾有限公司 | New bicyclic derivatives having [beta]2 adrenergic agonist and M3 muscarinic antagonist activities |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996019198A1 (en) * | 1994-12-22 | 1996-06-27 | Astra Aktiebolag | Aerosol drug formulations |
| US5668110A (en) * | 1995-06-07 | 1997-09-16 | Affymax Technologies N.V. | Peptides and compounds that bind to the IL-5 receptor |
-
1997
- 1997-12-12 SE SE9704644A patent/SE9704644D0/en unknown
-
1998
- 1998-12-10 JP JP2000538686A patent/JP2002508319A/en active Pending
- 1998-12-10 WO PCT/SE1998/002278 patent/WO1999030703A1/en not_active Ceased
- 1998-12-10 AU AU18971/99A patent/AU1897199A/en not_active Abandoned
- 1998-12-10 EP EP98963701A patent/EP1037620A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP1037620A1 (en) | 2000-09-27 |
| SE9704644D0 (en) | 1997-12-12 |
| WO1999030703A1 (en) | 1999-06-24 |
| JP2002508319A (en) | 2002-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1897199A (en) | Use of formoterol in medicament for inflammation/allergy in upper airways | |
| AU3445697A (en) | New use of xylitol and pharmaceutical compositions therefor | |
| IL113844A (en) | N-(alpha-ETHYLBENZYL)-3-HYDROXY-2-PHENYLQUINOLINE-4-CARBOXAMIDE AND ITS USE IN THE PREPARATION OF MEDICAMENTS | |
| AU2111199A (en) | Benzenesulfonamides and benzamides as therapeutic agents | |
| AU3003295A (en) | Improved inhaler and medicated package | |
| HUP0101293A3 (en) | Aspb28-human insulin comprising pharmaceutical composition administered by inhalation and their use | |
| EP0950665A4 (en) | Modified physiologically active proteins and medicinal compositions containing the same | |
| AU2505795A (en) | 1-arylpyrimidine derivatives and pharmaceutical use thereof | |
| AU1970495A (en) | Drug delivery device and method of construction | |
| IL134773A0 (en) | New use for budesonide and formoterol | |
| AU3373997A (en) | Medicinal aerosol formulations of formoterol | |
| IL125446A0 (en) | Pharmaceutical composition for the treatment of asthma allergy and inflammation | |
| HUP0202862A3 (en) | Pharmaceutical composition containing novel combination of loteprednol and antihistamines | |
| IL127572A (en) | Pharmaceutical composition and medicament for nasal administration | |
| HUP9902655A3 (en) | Pharmaceutical composition of hedgehog proteins and use thereof | |
| AUPO727097A0 (en) | Method of treatment of hepatoma and pharmaceutical compositions for use therein | |
| PL335555A1 (en) | Novel compounds - substituted benzamides and therapeutic agent | |
| AU1164601A (en) | Therapeutic use and formulation | |
| AU4305897A (en) | Pharmaceutical compositions containing amisulpride and therapeutic applications thereof | |
| AU6367496A (en) | New hormonal medicaments and their use for the correction of oestrogenic deficiencies | |
| AU1331399A (en) | Preparation for prevention and healing of inflammation affections | |
| AU5587800A (en) | S-(+)-desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions | |
| AU7001796A (en) | Benzoic acid compounds and medicinal use thereof | |
| AU1053501A (en) | Polyazanaphthalene compound and medicinal use thereof | |
| AU2529799A (en) | Benzofuran-4-carboxamides and their therapeutic use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |